Most EU countries require cost-effectiveness submissions for reimbursement purposes.
Ingress specializes in developing core models for reimbursement submissions
Ingress team members have developed various models for numerous chronic and acute diseases (e.g. decision tree, Markov, Dynamic models for infectious diseases and micro-simulation models). We can build these models for primary reimbursement purposes but also for conditional reimbursement purposes based on for instance relative effectiveness data derived from real-world evidence studies. Our EU patient-level data access allows us to develop models in which diseases progression is based on local real-world data. Alternatively, we can validate the model predictions by comparing it with real-world data. In addition, Ingress can also validate existing models by applying standardized validity checklists and we can organize international ad boards with clinicians and health-economists for model validation purposes.
By completing your details below you are agreeing to receive communications and updates from us including but not limited to news, the latest publications, and invitations to Ingress-Health company events.